Shares of Repros Therapeutics (RPRX) rocket up 13% in AH trading after the firm announces data...

|About: Repros Therapeutics Inc. (RPRX)|By:, SA News Editor

Shares of Repros Therapeutics (RPRX) rocket up 13% in AH trading after the firm announces data from a recent study showed a does of its Androxal treatment displays similar efficacy to similar FDA-approved testosterone-boosting gels.